Skip to main content
G

Giant Biogene Holding Co., Ltd — Investor Relations & Filings

Ticker · 2367 LEI · 391200HMPBKVFGL0V252 HKEX Manufacturing
Filings indexed 169 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2367

About Giant Biogene Holding Co., Ltd

http://www.xajuzi.com

Giant Biogene Holding Co., Ltd. is a biotechnology enterprise specializing in the research, development, manufacture, and distribution of professional skin treatment products and bioactive ingredients. The company utilizes proprietary synthetic biology platform technology to produce core components, primarily recombinant collagen and high-purity rare ginsenosides. Its recombinant collagen portfolio includes full-length and functionally enhanced variants engineered to be 100% identical to human collagen sequences. Giant Biogene applies these ingredients across three primary sectors: functional skincare products (under brands like Cofoe and Collgen), medical devices (including advanced injectable implants), functional foods, and special medical purpose formula foods. This technological focus establishes the company as a leader in bioactive ingredient-based professional skin care.

Recent filings

Filing Released Lang Actions
PROPOSED CHANGE OF AUDITORS
Regulatory Filings
2026-04-30 English
2025 Environmental, Social and Governance (ESG) Report
Regulatory Filings
2026-04-29 English
ANNUAL REPORT 2025
Regulatory Filings
2026-04-29 English
Next Day Disclosure Return
Regulatory Filings
2026-04-20 English
CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT IN HONG KONG
Board/Management Information Classification · 1% confidence The announcement is a Hong Kong Exchange filing regarding the resignation and appointment of the joint company secretary, authorised representative and process agent. This is an announcement of a change in the company’s senior management/board-related officer. Accordingly, it falls under the Board/Management Information category (MANG).
2026-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” (Form FF301) filed under Chapter 19B of the HKEX Listing Rules, detailing month-end movements in authorised share capital, issued shares, share options, repurchases, public float confirmation, etc. It is a periodic regulatory filing to the exchange rather than an investor presentation, earnings release, management discussion, or formal report like an annual or interim report. There is no specific category for monthly returns, so it falls under the catch-all “Regulatory Filings” category.
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.